Vaxine Pty Ltd - Adelaide, South Australia

+61 (0)420 878 911
admin@vaxine.net

Follow

Vaxine Vaxine
Skip to content
  • Home
  • About
    • About
    • People
  • Projects
  • Publications
  • News
  • Contact
  • Veterinary

Vaxine Pty Ltd - Adelaide, South Australia

+61 (0)420 878 911
admin@vaxine.net

Follow

Flinders University scientists led by Tasmanian Professor Nikolai Petrovsky on track to have a vaccine by the end of the year

 Category Vaxine Updates
July 2, 2020

The first COVID-19 vaccine to be developed in the southern hemisphere has progressed to human trials.

But the company behind it is funded by the United States’ National Institute of Allergy and Infectious Diseases, so will it stay in Australia?

Podcast:

https://www.abc.net.au/radio/hobart/programs/mornings/tas-scientist-says-aus-on-track-for-covid19-vaccine-by-2021/12419466
 Tags COVID-19 Vaccine
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Skype (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on Pocket (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
  • Click to print (Opens in new window)
RELATED STORIES
vamtam-theme-circle-post
 Category Vaxine Updates

COVID-19 Vaccine Zoo Collaboration

August 30, 2022
ZAA-accredited zoos welcome the opportunity to add an extra layer of protection to the health...
Read More
vamtam-theme-circle-post
 Category Vaxine Updates

Phase 2 trial results

April 22, 2022
Vaxine is pleased to see its latest Covid-19 vaccine Phase 2 trial results complete peer...
 Tags Trial Results
Read More
vamtam-theme-circle-post
 Category Vaxine Updates

TGA grants Provisional Determination to Vaxine for its COVID-19 Recombinant Protein Vaccine

April 1, 2022
The Therapeutic Goods Administration (TGA), part of the Department of Health, has granted provisional determination to Vaxine...
 Tags TGA
Read More
vamtam-theme-circle-post
 Category Vaxine Updates

Efficacy of COVID-19 vaccines (Video)

September 21, 2021
Amid the COVID-19 pandemic and the development of new vaccines, we hear the term “vaccine...
 Tags COVID-19 Vaccine, Efficacy, video
Read More
vamtam-theme-circle-post
 Category Vaxine Updates

Recent paper on use of our ADVAX-CPG Adjuvant in Herpes Simplex virus vaccine development

September 17, 2021
This latest paper highlights a Herpes simplex virus vaccine being developed in collaboration with our...
 Tags ADVAX-CPG Adjuvant, Publication, Research
Read More
vamtam-theme-circle-post
 Category Vaxine Updates

CinnaGen initiates a phase 3 clincial trial of Vaxine’s COVID-19 vaccine technology

August 17, 2021
On August 07, 2021, the first volunteer enrolled in the Phase 3 clinical study of Cinnagen’s COVID-19...
 Tags COVID-19 Vaccine, Trial Results
Read More
vamtam-theme-circle-post
 Category Vaxine Updates

Australian-made coronavirus vaccine shows promise in clinical trials

August 16, 2021
Vaxine’s COVID-19 vaccine technology has progressed to the final stages of a human clinical trial,...
 Tags COVID-19 Vaccine, Trial Results
Read More
vamtam-theme-circle-post
 Category Vaxine Updates

Promising clinical trial of Vaxine’s Covid-19 vaccine technology.

July 16, 2021
CinnaGen Co. announced that the results of preliminary analysis of data from the ongoing Phase 2...
 Tags COVID-19 Vaccine, Trial Results
Read More
vamtam-theme-circle-post
 Category Vaxine Updates

Can India prevent Covid-19 third wave? Global vaccine expert Professor Nikolai Petrovsky answers

July 5, 2021
TV9 News spoke to Prof Nikolai Petrovsky, PhD, senior researcher, an expert on vaccine development...
 Tags COVID-19
Read More
vamtam-theme-circle-post
 Category Vaxine Updates

Our modeling paper “In silico comparison of SARS-COV-2 spike protein-ace2 binding affinities across species and implications for virus origin” published in Nature Scientific Reports

June 25, 2021
Our Modeling paper on the origins of SARS-CoV-2 just got published by Nature Scientific Reports....
 Tags Publication, Research
Read More
https://vaxine.net/wp-content/uploads/2022/03/cropped-logo.png

Vaxine is an Australian-based biotechnology company that over the last 20 years has developed an extensive portfolio of vaccines and immunotherapies, including vaccines against Covid-19, influenza, hepatitis B, and Japanese encephalitis plus immunotherapies against allergy and cancer.  Underlying all these successful vaccines is Vaxine’s powerful vaccine adjuvant technology plus its capabilities in applying artificial intelligence to rapid drug design.

  • About
  • People
  • Projects
  • Publications
  • News
  • Contact

News

  • COVID-19 Vaccine Zoo Collaboration August 30, 2022
  • Phase 2 trial results April 22, 2022
  • TGA grants Provisional Determination to Vaxine for its COVID-19 Recombinant Protein Vaccine April 1, 2022
Read more

© 2022 Vaxine Pty Ltd. All rights reserved.
Made with ❤ by Howdy Innovation


Flinders University targets Covid-19 vaccineSypharma partners with Vaxine to manufacture Covid-19 vaccine product